statistiche ricercatore

MORTARA, LORENZO

Distribuzione geografica

Continente	#
EU - Europa	11.672
NA - Nord America	10.317
AS - Asia	1.953
Continente sconosciuto - Info sul continente non disponibili	16
OC - Oceania	11
SA - Sud America	7
AF - Africa	4
Totale	23.980

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	10.305
IT - Italia	7.047
UA - Ucraina	1.784
TR - Turchia	773
SE - Svezia	655
VN - Vietnam	556
CN - Cina	517
DE - Germania	477
IE - Irlanda	477
FI - Finlandia	435
FR - Francia	399
GB - Regno Unito	194
IN - India	50
BE - Belgio	36
CH - Svizzera	24
NL - Olanda	20
ES - Italia	18
AT - Austria	17
PL - Polonia	16
SG - Singapore	15
EU - Europa	14
JP - Giappone	12
CA - Canada	11
PT - Portogallo	9
RO - Romania	9
RU - Federazione Russa	9
AU - Australia	8
NO - Norvegia	6
HK - Hong Kong	5
MD - Moldavia	5
TH - Thailandia	5
BG - Bulgaria	4
BR - Brasile	4
HU - Ungheria	4
EE - Estonia	3
IL - Israele	3
IR - Iran	3
LU - Lussemburgo	3
MK - Macedonia	3
NZ - Nuova Zelanda	3
RS - Serbia	3
SK - Slovacchia (Repubblica Slovacca)	3
A2 - ???statistics.table.value.countryCode.A2???	2
AR - Argentina	2
DK - Danimarca	2
EG - Egitto	2
MC - Monaco	2
MT - Malta	2
PK - Pakistan	2
SC - Seychelles	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
BD - Bangladesh	1
CL - Cile	1
CY - Cipro	1
CZ - Repubblica Ceca	1
GL - Groenlandia	1
GR - Grecia	1
HR - Croazia	1
ID - Indonesia	1
IQ - Iraq	1
KW - Kuwait	1
KZ - Kazakistan	1
LI - Liechtenstein	1
MY - Malesia	1
NP - Nepal	1
PH - Filippine	1
SA - Arabia Saudita	1
TW - Taiwan	1
Totale	23.980

Salva come PNG Salva come JPEG

Città	#
Milan	4.116
Jacksonville	1.342
Chandler	1.254
Fairfield	1.025
Woodbridge	773
Ann Arbor	629
Ashburn	599
Houston	517
Princeton	491
Dublin	470
Wilmington	456
Dearborn	421
Izmir	400
Nyköping	379
Seattle	344
Rome	319
Cambridge	317
Dong Ket	314
Como	304
Beijing	172
San Mateo	162
New York	97
San Diego	95
Kocaeli	93
Ogden	84
Hefei	50
Los Angeles	48
Verona	48
Turin	45
Boardman	43
Düsseldorf	39
Kunming	39
Nanjing	39
London	38
Brussels	36
Helsinki	35
Florence	32
Jinan	32
Washington	32
Norwalk	29
Genoa	28
Berlin	21
Guangzhou	21
Pune	21
Redmond	20
Varese	18
Frankfurt am Main	15
Magnago	15
Naples	15
Nanchang	14
Bologna	13
Shenyang	13
Brescia	12
Fuzhou	12
Bari	11
Garbagnate Milanese	11
Changsha	10
Gorgonzola	10
Padova	10
Ponte Lambro	10
West Jordan	10
Chengdu	9
Hebei	9
Modena	9
Redwood City	9
Treviso	9
Vienna	9
Paris	8
Siena	8
Singapore	8
Stockholm	8
Edinburgh	7
Graz	7
Parma	7
Perugia	7
Philadelphia	7
Ravenna	7
Reggio Emilia	7
Rozzano	7
Tokyo	7
Trieste	7
Auburn Hills	6
Chicago	6
Lausanne	6
Monza	6
Pittsburgh	6
Quzhou	6
San Genesio Ed Uniti	6
San Giuliano	6
Taranto	6
Vigevano	6
Acton	5
Athis-mons	5
Baotou	5
Catania	5
Chieti	5
Falls Church	5
Kilburn	5
Lisbon	5
Mountain View	5
Totale	16.329

Salva come PNG Salva come JPEG

Nome	#
Allergie e intolleranze. Icone di immunopatologia.	1.667
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	212
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	191
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?	188
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	184
Grading of laboratories on CD4+T-lymphocyte evaluations based on acceptable data boundaries defined by the measurement error	183
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	178
DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus (SIVagm)	161
Orchestration of angiogenesis by immune cells	161
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects	160
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.	156
Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons.	155
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	155
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	155
Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period.	154
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS	154
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells	153
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	152
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	151
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	151
Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication	150
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	150
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression	149
New strategies of mammary cancer vaccination	147
CD56(bright)CD16(-) NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4(+) T Cell Proliferation	147
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	146
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.	145
Schedule-dependent therapeutic efficacy of L19mTNF-a and Melphalan combined with Gemcitabine	145
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	144
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	142
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	141
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	138
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	136
Recognition of human T Leukaemia virus (HTLV-I) envelope by human CD4+ T cell lines from HTLV-I seronegative individuals: specificity and clonal heterogeneity.	134
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	132
Selection of virus variants and emergence of virus escape mutants after immunization with epitope vaccine	131
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	127
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	127
Tumor Vasculature Targeted TNFα Therapy: Reversion of Microenvironment Anergy and Enhancement of the Anti-tumor Efficiency.	125
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	123
Type 1 CD4+ T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptide vaccine in rhesus macaques.	120
Down syndrome, autoimmunity and T regulatory cells	119
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	118
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	118
Plasmocytoid dendritic cell dynamics and alpha IFN production during Simian Immunodeficiency Virus infection with a nonpathogenic outcome	115
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy	115
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	115
Analysis of the antigen specific T cell repertoire in HIV infection	112
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	111
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy	109
Therapy-induced antitumor vaccination by targeting tumor necrosis factor  to tumor vessels in combination with melphalan	108
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	108
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	106
Targeted delivery of TNF-alpha to tumor vessels induces a strong cell-mediated immune response against homologous and heterologous tumors.	105
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	105
Early triggering of natural killer and dendritic cell during antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	105
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	102
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells	100
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	100
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions	99
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.	99
Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	99
Early functional activation of natural killer cell and dendritic cell during the antitumor therapeutic response induced by TNFa tumor vessel delivery and melphalan	99
Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes	98
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset	98
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	98
Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.	97
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	97
Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer	97
Analyse de DC-SIGN dans un modèle de résistance au SIDA	95
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state.	95
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota	95
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	93
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors.	93
Sequential Immunogene Therapy with Interleukin-12- and Interleukin-15-Engineered Neuroblastoma Cells Cures Metastatic Disease in Syngeneic Mice.	92
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature	92
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients	92
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	92
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	91
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	91
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis	91
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	90
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC)	90
The challenge of prognostic markers in pleural mesothelioma	90
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	90
Functional and phenotypic characterization of tumor infiltrating NK cells.	89
Fine characterization of macaque cytotoxic T lymphocytes (CTL) induced by lipopeptides into rhesus macaques. Optimization of lipopeptide immunization to induce multispecific CTL	89
Analysis of the selection pressure by the NEF-immunodominant macaque CTL response in SIV infection	89
VEGFR2 and CXCR4 pathways are modulated by acetyl-l-Carnitine that acts as an anti-angiogenic agent	89
In vivo containment of SIV replication associated with induction of broad multispecific cytotoxic T lymphocytes directed against conserved viral epitopes	88
Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class-II molecules combined with naked DNA interleukin-12 gene transfer	88
The rnaset2 oncosuppressor protein regulates both differentiation and polarization in human macrophages	88
Early induction of an anti-inflammatory environment during primary SIVagm infection	87
Impact of SIV lipopeptide vaccination on survival of macaques: major role of CTL responses on delaying onset of AIDS	87
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.	87
NK cells as modulators of tumor angiogenesis	87
Functional and phenotypic characterization of tumor infiltrating NK cells to identify novel targets for anticancer therapy.	86
Irradiated CIITA-positive mammary adenocarcinoma cells act as potent anti-tumor preventive vaccine by inducine tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	85
Monospecific CTL induced into rhesus macaques by lipopeptidic immunization select viral variants and mutants	85
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model	85
Totale	13.453

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	71.153
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	71.153

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	861	0	0	0	0	0	0	0	0	0	0	268	593
2019/2020	3.480	113	92	113	516	121	384	673	524	223	330	101	290
2020/2021	3.310	54	320	98	306	100	330	129	294	567	282	315	515
2021/2022	2.479	306	286	212	113	100	56	134	165	213	317	220	357
2022/2023	3.904	335	198	250	412	267	774	60	487	521	189	203	208
2023/2024	7.016	1.081	1.086	1.114	1.210	1.244	513	132	168	216	246	6	0
Totale													24.274